港股異動 | 中播控股一度大漲逾22% 智能駕駛技術取得突破
格隆匯4月20日丨中播控股(0471.HK)今日高開高走,一度大漲逾22%,現漲幅收窄至8.06%,報0.335港元,暫成交838萬港元,最新總市值7606萬港元。中播控股上週五(17日)盤後發公告稱,公司在智能駕駛技術開發領域取得了突破,並提交了美國專利申請,名為“雷達 -攝像頭傳感器融合技術與裝置”。此類應用的市場規模預計到2027年將超過2000億美元。此技術方案將能取代自動駕駛對昂貴激光雷達方案的需求,提供更完善功能,使自動駕駛車輛變得更安全,低成本,和大眾化。目前公司正與汽車產業夥伴洽談有關技術的商業採用和市場推廣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.